CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

BACKGROUND: The identification of high-risk stage II colon cancers is key to the selection of patients who require adjuvant treatment after surgery. Microarray-based multigene-expression signatures derived from stem cells and progenitor cells hold promise, but they are difficult to use in clinical p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Dalerba, Piero, Sahoo, Debashis, Paik, Soonmyung, Guo, Xiangqian, Yothers, Greg, Song, Nan, Wilcox-Fogel, Nate, Forgó, Erna, Rajendran, Pradeep S., Miranda, Stephen P., Hisamori, Shigeo, Hutchison, Jacqueline, Kalisky, Tomer, Qian, Dalong, Wolmark, Norman, Fisher, George A., van de Rijn, Matt, Clarke, Michael F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4784450/
https://ncbi.nlm.nih.gov/pubmed/26789870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1506597
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados